Clinical Trials for Refractory Malignant Solid Tumors

Find clinical trials for refractory malignant solid tumors. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity

NCT ID: NCT07100210

This clinical trial is testing a new treatment called IL-22BP/LNP in people with certain types of advanced cancer that have not responded to previous treatments. These cancers include soft tissue s...

Not yet recruiting

Phase: PHASE1 Type: interventional

Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.

NCT ID: NCT07040943

This clinical trial is testing a new treatment called IL-22BP for adults with certain types of advanced solid tumors—cancers that have not responded to at least two previous treatments and for whic...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Chengdu, Sichuan, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions